SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-061289
Filing Date
2022-05-16
Accepted
2022-05-16 16:06:19
Documents
14
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2215441d1_8k.htm   iXBRL 8-K 24400
2 EXHIBIT 99.1 tm2215441d1_ex99-1.htm EX-99.1 90219
6 GRAPHIC tm2215441d1_ex99-1img01.jpg GRAPHIC 3876
  Complete submission text file 0001104659-22-061289.txt   308935

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA albo-20220516.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20220516_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20220516_pre.xml EX-101.PRE 22605
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2215441d1_8k_htm.xml XML 3575
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 22928815
SIC: 2834 Pharmaceutical Preparations